| Achieving universal genetic assessment for women with ovarian cancer: Are we there yet? A systematic review and meta-analysis J Lin, RN Sharaf, R Saganty, D Ahsan, J Feit, A Khoury, H Bergeron, ... Gynecologic Oncology 162 (2), 506-516, 2021 | 49 | 2021 |
| Cascade testing for hereditary cancer syndromes: should we move toward direct relative contact? A systematic review and meta-analysis MK Frey, MD Ahsan, H Bergeron, J Lin, X Li, RK Fowlkes, P Narayan, ... Journal of Clinical Oncology 40 (35), 4129-4143, 2022 | 43 | 2022 |
| Do people with hereditary cancer syndromes inform their at-risk relatives? A systematic review and meta-analysis MD Ahsan, SR Levi, EM Webster, H Bergeron, J Lin, P Narayan, ... PEC innovation 2, 100138, 2023 | 8 | 2023 |
| What happens in the long term: Uptake of cancer surveillance and prevention strategies among at‐risk relatives with pathogenic variants detected via cascade testing MK Frey, MD Ahsan, N Badiner, J Lin, P Narayan, R Nitecki, ... Cancer 128 (24), 4241-4250, 2022 | 7 | 2022 |
| Autologous Fat Grafting as a Stand-alone Method for Immediate Breast Reconstruction After Radical Mastectomy in a Series of 15 Patients A Fitoussi, K Razzouk, MD Ahsan, G Andrews, A Rafii Annals of Plastic Surgery 88 (1), 25-31, 2022 | 7 | 2022 |
| Prevalence and associated factors of restless leg syndrome (RLS) in Pakistani women during pregnancy SM Mubeen, MD Ahsan Journal of Obstetrics and Gynaecology 42 (6), 1829-1834, 2022 | 5 | 2022 |
| Web-based tool for cancer family history collection: A prospective randomized controlled trial MK Frey, MD Ahsan, E Webster, SR Levi, JT Brewer, J Lin, SV Blank, ... Gynecologic Oncology 173, 22-30, 2023 | 4 | 2023 |
| Barriers to completion of cascade genetic testing: how can we improve the uptake of testing for hereditary breast and ovarian cancer syndrome? RM Kahn, MD Ahsan, E Chapman-Davis, K Holcomb, R Nitecki, ... Familial Cancer 22 (2), 127-133, 2023 | 4 | 2023 |
| Room for improvement in capturing cancer family history in a gynecologic oncology outpatient setting J Lin, I Wolfe, MD Ahsan, H Krinsky, AI Lackner, J Pelt, K Bolouvi, ... Gynecologic oncology reports 40, 100941, 2022 | 4 | 2022 |
| Underrepresentation of racial and ethnic minorities in cascade testing for hereditary cancer syndromes MD Ahsan, EM Webster, NT Nguyen, M Qazi, SR Levi, LC Diamond, ... European Journal of Human Genetics 31 (7), 723-724, 2023 | 3 | 2023 |
| Patient perspectives on risk-reducing salpingectomy with delayed oophorectomy for ovarian cancer risk-reduction: A systematic review of the literature L Perez, E Webster, L Bull, JT Brewer, MD Ahsan, J Lin, SR Levi, ... Gynecologic Oncology 173, 106-113, 2023 | 3 | 2023 |
| Risk of gastric cancer and utility of endoscopic screening for lynch syndrome patients A Bar-Mashiah, MD Ahsan, R McGonigle, RN Sharaf Foregut 3 (1), 60-68, 2023 | 2 | 2023 |
| Using health information technology to improve collection of family cancer history: prospective randomized trial of web-based tool in a gynecologic oncology outpatient clinic M Frey, J Lin, H Krinsky, C Nchako, K Bolouvi, D Litvin, N Wing, C Thomas, ... Gynecologic Oncology 162, S31-S32, 2021 | 2 | 2021 |
| Implementation of a smartphone survey and mainstreaming for genetic cancer risk assessment in a diverse, urban, Medicaid-predominant gynecology clinic: a step toward health equity EM Webster, MD Ahsan, A McDougale, RN Sharaf, MK Frey American Journal of Obstetrics & Gynecology, 2024 | 1 | 2024 |
| Partner and localizer of BRCA2 (PALB2) pathogenic variants and ovarian cancer: A systematic review and meta-analysis. P Narayan, MD Ahsan, EM Webster, L Perez, SR Levi, B Harvey, I Wolfe, ... Gynecologic Oncology 177, 72-85, 2023 | 1 | 2023 |
| Chatbot Artificial Intelligence for Genetic Cancer Risk Assessment and Counseling: A Systematic Review and Meta-Analysis EM Webster, MD Ahsan, L Perez, SR Levi, C Thomas, P Christos, ... JCO clinical cancer informatics 7, e2300123, 2023 | 1 | 2023 |
| Hereditary breast and ovarian cancer syndrome: A misnomer? JM Weiss, MD Ahsan, EM Webster, SR Levi, M Qazi, B Harvey, E Cantillo, ... Journal of Clinical Oncology 41 (16_suppl), 10594-10594, 2023 | 1 | 2023 |
| Socio-ecological model of barriers to cascade testing for hereditary cancer syndromes: Systematic review of the literature (057) X Li, MD Ahsan, J Feit, S Ratner, K Holcomb, E Chapman-Davis, ... Gynecologic Oncology 166, S38-S39, 2022 | 1 | 2022 |
| Health information technology to improve referral to genetic testing for high-risk patients in a gynecologic oncology clinic (102) I Wolfe, A Cornelius-Schecter, MD Ahsan, E Miller, C Nchako, S Dioun, ... Gynecologic Oncology 166, S68-S69, 2022 | 1 | 2022 |
| Cascade testing for hereditary cancer syndromes: Should we move towards direct relative contact? A systematic review and meta-analysis (384) MD Ahsan, H Bergeron, J Lin, R Fowlkes, P Narayan, R Nitecki, ... Gynecologic Oncology 166, S196, 2022 | 1 | 2022 |
